Clinipace recognized as the fastest growing private company in the Triangle
Morrisville, NC (Business Wire) November 16, 2011 — Clinipace Worldwide, a global digital contract research organization (dCRO) that has pioneered technology-amplified contract research services, today announced it has been named the #1 fastest growing private company in the Triangle. This is the second consecutive year Clinipace Worldwide has been named to Triangle Business Journal’s Fast 50 list. The winners were selected and ranked based on revenue growth, percentage rate of growth, and profitability over a three-year period, analyzed by PricewaterhouseCoopers.
“There is a tremendous opportunity to serve the unique needs of emerging and mid-market biopharmaceutical and medical device firms; a segment that values innovative solutions to drive efficiencies,” said Jeff Williams, CEO, Clinipace Worldwide. “I proudly accepted the award on behalf of every employee and client who work hard every day to improve the lives of patients worldwide and how clinical research is performed.”
Clinipace Worldwide was able to reach its Fast 50 status because of recent successes such as:
- Actively managing over 150 projects worldwide; and signed over 35 new clients throughout 2011
- Closing of $15M Series C round of funding led by Morgan Stanley Expansion Capital
- Three acquisitions within the past 18 months
- Ranked 279 overall and 20th among Inc.’s list of Top Heath Companies for 2011 as a result of 1,170% growth over the past three-year period, Clinipace Worldwide joins the rarified company of organizations that have appeared on the list multiple times
About Clinipace Worldwide
Clinipace Worldwide, a global digital contract research organization (dCRO), specializes in fully-integrated contract research services for biopharmaceutical and medical device firms. Optimized by TEMPO™, its proprietary eClinical platform, the Clinipace team of experts brings extensive knowledge and insight into site selection, patient recruitment, clinical operations, data management, medical monitoring, biostatistics, and regulatory affairs to ensure a successful clinical development program through proactive clinical trial management. With specific expertise in oncology, among other therapeutic areas, Clinipace Worldwide has managed over 500 global contract research and regulatory projects. Clinipace Worldwide is headquartered in Research Triangle Park, North Carolina with offices in Overland Park, Kansas, Boulder, Colorado, Zurich, Switzerland, Munich, Germany, Tel-Aviv, Israel, New Delhi, India, Sao Paulo, Brazil, Buenos Aires, Argentina, and Lima, Peru. For more information visit our website at www.clinipace.com.